4 Key Takeaways | Solar Industry & Chinese Tariff Update
Wiley's 10 Key Trade Developments: The CHIPS Act and Inflation Reduction Act (IRA)
Contratación para el Desarrollo de Infraestructura del Agua
El Plan Nacional de Desarrollo
Introducing TAG Infrastructure with Board Chair Sarah Ellis - TAG Infrastructure Talks Podcast
Introducing TAG Infrastructure Talks - TAG Infrastructure Talks Podcast
No Password Required: The Former NSA Director and Storyteller Whose Life Resembles a Grisham Novel
Protection of Critical Infrastructure via LIPA and ICTS
Energy + Cybersecurity: What's In the Pipeline? [More with McGlinchey Ep. 23]
On-Demand Webinar | Living on the Edge: Managing Sea Level Rise in California
On-Demand Webinar | Eminent Domain in 2020: A Year in Review
DHS and Cyber: What Should Companies Expect?
#WorkforceWednesday: Guidance for Critical Infrastructure Workers; OSHA Reporting Guidance; EEOC Update - Employment Law This Week®
AF COVID-19 PODCAST: Can Construction Projects Move Forward?
Podcast: CFIUS Update: Key Takeaways from the FIRRMA Implementing Regulations
Compliance Perspectives: The FBI on Why and How to Work with the Office of the Private Sector
Jones Day Talks: Italy Embraces Foreign investment but Maintains Oversight
Jones Day Talks: Doing Deals Down Under: Australia's Foreign Direct Investment Regime
Jones Day Talks: Navigating Foreign Direct Investment in Germany
China’s new cybersecurity law
The Big Picture - On November 19, the House of Representatives passed the Build Back Better Act (BBB) (H.R. 5376) by a vote of 220–213. The BBB contains a number of health and social policy priorities that are widely viewed...more
On September 10, the newly-formed White House Competition Council (the “Council” or “Competition Council”) held its inaugural meeting, bringing together eight cabinet members and the leaders of seven independent agencies, to...more
The Big Picture - Before leaving for its August recess, the Senate made progress on two major Biden Administration priorities by passing bipartisan infrastructure legislation and a fiscal year (FY) 2022 budget resolution....more
The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H.R. 19, the “Lower Costs, More Cures Act of 2021” and a reintroduced...more
Under President Joe Biden, pharmaceutical regulation may see increased FDA guidance, new strategies to speed up innovation and regulatory review, and a renewed focus on diseases with unmet needs, among other expectations....more
Washington saw a flurry of bipartisan activity over the last few weeks. Most notably, Republican and Democratic negotiators reached a long-awaited deal on sequestration budget caps. The compromise, announced on February 7 as...more